IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ROBIN L SUTCLIFFE

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1730490921
CMS profile
10672349
Location
LEXINGTON, KY

General Payments · PY2021–2024

$8,003.27

  • Reported across 442 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,155.68

50 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Family KY All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,155.68 50

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Phathom Pharmaceuticals, Inc. $242.74 3
ABBVIE INC. $179.84 11
Salix Pharmaceuticals, a division of Bausch Health US, LLC $178.24 9
AIMMUNE THERAPEUTICS, INC. $89.02 3
Janssen Biotech, Inc. $67.36 3
GENZYME CORPORATION $64.01 3
Novo Nordisk AS $47.93 3
Lilly USA, LLC $46.98 2
Takeda Pharmaceuticals U.S.A., Inc. $46.98 3
Boehringer Ingelheim Pharmaceuticals, Inc. $36.37 2
Sandoz Inc. $24.61 1
QOL Medical, LLC $23.32 1
Celgene Corporation $20.41 1
Regeneron Healthcare Solutions, Inc. $20.37 1
INTERCEPT PHARMACEUTICALS, INC. $18.99 1
Ardelyx, Inc. $18.47 1
PFIZER INC. $15.85 1
Gilead Sciences, Inc. $14.19 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $2,288.51 131
PY2022 $2,189.78 131
PY2023 $2,369.30 130
PY2024 $1,155.68 50

Payment records · PY2024 (50)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $10.18 01/03/2024 Food and Beverage Undisputed 01/23/2026 1108274828 CMS
ABBVIE INC. $14.22 01/09/2024 Food and Beverage Undisputed 01/23/2026 1108274830 CMS
ABBVIE INC. $21.72 01/16/2024 Food and Beverage Undisputed 01/23/2026 1108274832 CMS
ABBVIE INC. $17.61 01/31/2024 Food and Beverage Undisputed 01/23/2026 1108274834 CMS
ABBVIE INC. $17.22 02/19/2024 Food and Beverage Undisputed 01/23/2026 1108274836 CMS
ABBVIE INC. $14.87 02/26/2024 Food and Beverage Undisputed 01/23/2026 1108274838 CMS
ABBVIE INC. $19.65 02/28/2024 Food and Beverage Undisputed 01/23/2026 1108274840 CMS
ABBVIE INC. $18.43 03/12/2024 Food and Beverage Undisputed 01/23/2026 1108274842 CMS
ABBVIE INC. $4.79 03/12/2024 Food and Beverage Undisputed 01/23/2026 1108274844 CMS
ABBVIE INC. $13.91 03/20/2024 Food and Beverage Undisputed 01/23/2026 1108274846 CMS
ABBVIE INC. $27.24 03/27/2024 Food and Beverage Undisputed 01/23/2026 1108274848 CMS
AIMMUNE THERAPEUTICS, INC. $33.28 03/08/2024 Food and Beverage Undisputed 01/23/2026 1147016427 CMS
AIMMUNE THERAPEUTICS, INC. $27.87 04/17/2024 Food and Beverage Undisputed 01/23/2026 1146959813 CMS
AIMMUNE THERAPEUTICS, INC. $27.87 04/17/2024 Food and Beverage Undisputed 01/23/2026 1146966252 CMS
Ardelyx, Inc. $18.47 03/11/2024 Food and Beverage Undisputed 01/23/2026 1146747291 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $20.67 01/22/2024 Food and Beverage Undisputed 01/23/2026 1118132149 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.70 03/26/2024 Food and Beverage Undisputed 01/23/2026 1118132147 CMS
Celgene Corporation $20.41 01/04/2024 Food and Beverage Undisputed 01/23/2026 1101142282 CMS
GENZYME CORPORATION $16.49 01/17/2024 Food and Beverage Undisputed 01/23/2026 1139707751 CMS
GENZYME CORPORATION $23.80 02/05/2024 Food and Beverage Undisputed 01/23/2026 1139707759 CMS
GENZYME CORPORATION $23.72 03/25/2024 Food and Beverage Undisputed 01/23/2026 1139707779 CMS
Gilead Sciences, Inc. $14.19 03/29/2024 Food and Beverage Undisputed 01/23/2026 1133682425 CMS
Intercept Pharmaceuticals, Inc. $18.99 01/12/2024 Food and Beverage Undisputed 01/23/2026 1113654743 CMS
Janssen Biotech, Inc. $25.42 02/12/2024 Food and Beverage Undisputed 01/23/2026 1078651494 CMS
Janssen Biotech, Inc. $24.61 03/19/2024 Food and Beverage Undisputed 01/23/2026 1078652913 CMS
Janssen Biotech, Inc. $17.33 04/10/2024 Food and Beverage Undisputed 01/23/2026 1078653547 CMS
Lilly USA, LLC $19.36 01/08/2024 Food and Beverage Undisputed 01/23/2026 1135936978 CMS
Lilly USA, LLC $27.62 03/15/2024 Food and Beverage Undisputed 01/23/2026 1135953787 CMS
Novo Nordisk Inc $14.77 04/17/2024 Food and Beverage Undisputed 01/23/2026 1100253456 CMS
Novo Nordisk Inc $14.70 06/13/2024 Food and Beverage Undisputed 01/23/2026 1100512465 CMS
Novo Nordisk Inc $18.46 10/23/2024 Food and Beverage Undisputed 01/23/2026 1100631725 CMS
PFIZER INC. $15.85 02/07/2024 Food and Beverage Undisputed 01/23/2026 1131823544 CMS
Phathom Pharmaceuticals, Inc. $15.37 01/29/2024 Food and Beverage Undisputed 01/23/2026 1151209225 CMS
Phathom Pharmaceuticals, Inc. $113.97 02/27/2024 Food and Beverage Undisputed 01/23/2026 1151209227 CMS
Phathom Pharmaceuticals, Inc. $113.40 08/29/2024 Food and Beverage Undisputed 01/23/2026 1151209229 CMS
QOL Medical, LLC $23.32 01/14/2024 Food and Beverage Undisputed 01/23/2026 1147744706 CMS
Regeneron Healthcare Solutions, Inc. $20.37 03/04/2024 Food and Beverage Undisputed 01/23/2026 1114379215 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.11 01/03/2024 Food and Beverage Undisputed 01/23/2026 1153557483 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.16 01/29/2024 Food and Beverage Undisputed 01/23/2026 1153558847 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $21.39 02/01/2024 Food and Beverage Undisputed 01/23/2026 1153680556 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.18 02/14/2024 Food and Beverage Undisputed 01/23/2026 1153474088 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.02 03/06/2024 Food and Beverage Undisputed 01/23/2026 1153496978 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.98 03/27/2024 Food and Beverage Undisputed 01/23/2026 1153693146 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.42 04/10/2024 Food and Beverage Undisputed 01/23/2026 1153496704 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.98 04/10/2024 Food and Beverage Undisputed 01/23/2026 1153563552 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.00 04/24/2024 Food and Beverage Undisputed 01/23/2026 1153517052 CMS
Sandoz Inc. $24.61 02/07/2024 Food and Beverage Undisputed 01/23/2026 1089374069 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.27 01/03/2024 Food and Beverage Undisputed 01/23/2026 1137830833 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.76 02/27/2024 Food and Beverage Undisputed 01/23/2026 1137830835 CMS
Takeda Pharmaceuticals U.S.A., Inc. $14.95 03/21/2024 Food and Beverage Undisputed 01/23/2026 1137830837 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.